𝔖 Bobbio Scriptorium

✦ LIBER ✦

Evaluating the efficacy and safety of the novel vasopressin V1A- and V2-receptor antagonist conivaptan for the treatment of acute decompensated chronic heart failure: study protocol

✍ Scribed by Steven R. Goldsmith; Joseph G. Bisaha; Neila Smith

Book ID: 119212433
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 89 KB
Volume: 10
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2004.06.247

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of the Vasopressin V

Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study

✍ Steven R. Goldsmith; Uri Elkayam; W. Herbert Haught; Abhijit Barve; Weizhong He 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Conivaptan, a Vasopressin-Receptor Antag

Conivaptan, a Vasopressin-Receptor Antagonist, for the Treatment of Hyponatremia in Patients with and without Underlying Heart Failure

✍ Jalal K. Ghali; Bo Yan; Bruce McNutt 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Effect of Rolofylline, a Selective Adeno

Effect of Rolofylline, a Selective Adenosine A1 Receptor Antagonist, in Patients Hospitalized for Acute Decompensated Heart Failure and Renal Impairment: Findings from the PROTECT Study

✍ M. Christopher O'Connor 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Design and Rationale of the PROTECT Stud

Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function

✍ Beth Davison Weatherley; Gad Cotter; Howard C. Dittrich; Paul DeLucca; George A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Re: David Bar-Or, Kristin M. Salottolo,

Re: David Bar-Or, Kristin M. Salottolo, Alessandro Orlando, James V. Winkler. A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes. Eur Urol 2012;61:736–43

✍ Christopher C.K. Ho 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Reply to Christopher C.K. Ho's Letter to

Reply to Christopher C.K. Ho's Letter to the Editor re: David Bar-Or, Kristin M. Salottolo, Alessandro Orlando, James V. Winkler. A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes. Eur Urol 2012;61:736–43

✍ David Bar-Or; Kristin M. Salottolo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB